Press releases

Année :
Release
14.05.2019

VALBIOTIS will present the results of the international Phase IIA clinical study of VALEDIA® before 31 July 2019

Download
Release
02.04.2019

VALBIOTIS received two public subventions for a total amount of 885 000 euros

Download
Release
22.03.2019

VALBIOTIS presents its 2019 financial calendar

Download
Release
19.03.2019

VALBIOTIS strengthens its Supervisory Board with the appointment of Agnès TIXIER

Download
Release
11.03.2019

VALBIOTIS reports exclusive data on the prediabetes market: a considerable potential for VALEDIA®

Download
Release
08.03.2019

VALBIOTIS Provides 2018 Financial Results and Corporate Update

Download
Release
11.02.2019

VALBIOTIS obtains the European patent for VALEDIA®

Download
Release
04.02.2019

VALBIOTIS strengthens its Board of Directors with the appointment of Murielle CAZAUBIEL

Download
Release
30.01.2019

Update on the liquidity contract (in French)

Download